Administrative Core (A) is the innovative and synergistic engine driving the Penn CFAR, a collaboration ofthe University of Pennsylvania and its Perelman School of Medicine, Children's Hospital of Philadelphia, and Wistar Institute. Core A establishes and oversees Shared Resource Cores, educational activities, a Developmental Core, mentoring activities of junior investigators, and initiatives that build strong ties to the campus and community. Core A will continue to be led by Director James Hoxie, MD and Co- Director Ronald Collman, MD. Core A works closely with a governing Executive Committee, Internal Advisory Board, External Advisory Committee, and Community Advisory Board. In addition to the Cores, Core A oversees the CFAR's 4 Research Areas (Virology/Pathogenesis, Clinical/Therapeutics, Immunology vaccine, Behavioral &Social Sciences) and the new Scientific Working Groups (SWGs) (Viral Hepatitis &HIV Co-Infection, HIV Eradication &Functional Control, AIDS &Addiction). Core A provides the management and scientific direction for the CFAR and establishes the necessary linkages among participants. Core A's primary responsibilities are to 1) facilitate communication among CFAR members;2) lead a robust and transparent strategic planning process: 3) ensure that opportunities in emerging scientific areas and technologies in HIV/AIDS research are recognized and pursued: 4) ensure that Core facilities serve the research needs of members and comply with the policies by which they were established;5) enforce sound fiscal management and accountability for Core activities and Developmental funds;6) create multidisciplinary and vibrant educational programs for faculty and students;7) provide resources, organizational capacity, and scientific direction to CFAR SWGs;8) pursue strong outreach programs that address the needs of domestic and international populations most affected by the HIV epidemic;9) foster collaborations throughout the national CFAR network: and 10) promote diversity and inclusion in all CFAR activities. Core A is deeply committed to initiatives that build strong ties for the CFAR to the campus and the Philadelphia community, the CFAR network, and to international programs of Core I and inter-CFAR collaborations.
For 14 years, Core A has led the Penn CFAR in creating an interactive and collaborative HIV/AIDS research climate, vibrant educational activities, and innovative community outreach programs. Core A conducts, coordinates, and monitors CFAR activities to build infrastructure that fosters interdisciplinary and translational HIV/AIDS research and provides scientific leadership. It has also played the leadership role in the strategic planning process that has defined the exciting action plan for the next funding period.
|Gross, Robert; Bandason, Tsitsi; Langhaug, Lisa et al. (2015) Factors associated with self-reported adherence among adolescents on antiretroviral therapy in Zimbabwe. AIDS Care 27:322-6|
|Safren, Steven A; Biello, Katie B; Smeaton, Laura et al. (2014) Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial. PLoS One 9:e104178|
|Muluneh, Melaku; Shang, Wu; Issadore, David (2014) Track-etched magnetic micropores for immunomagnetic isolation of pathogens. Adv Healthc Mater 3:1078-85|
|Wohl, David A; Arnoczy, Gretchen; Fichtenbaum, Carl J et al. (2014) Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study. Antivir Ther 19:141-7|
|Nachega, Jean B; Parienti, Jean-Jacques; Uthman, Olalekan A et al. (2014) Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials. Clin Infect Dis 58:1297-307|
|Zetola, Nicola M; Modongo, Chawangwa; Olabiyi, Bisayo et al. (2014) Examining the relationship between alcohol use and high-risk sex practices in a population of women with high HIV incidence despite high levels of HIV-related knowledge. Sex Transm Infect 90:216-22|
|Haas, David W; Kwara, Awewura; Richardson, Danielle M et al. (2014) Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes. J Antimicrob Chemother 69:2175-82|
|Ramirez, Lorenzo A; Daniel, Alexander; Frank, Ian et al. (2014) Seroprotection of HIV-infected subjects after influenza A(H1N1) vaccination is directly associated with baseline frequency of naive T cells. J Infect Dis 210:646-50|
|Liu, Weimin; Li, Yingying; Shaw, Katharina S et al. (2014) African origin of the malaria parasite Plasmodium vivax. Nat Commun 5:3346|
|Blank, Michael B; Hennessy, Michael; Eisenberg, Marlene M (2014) Increasing quality of life and reducing HIV burden: the PATH+ intervention. AIDS Behav 18:716-25|
Showing the most recent 10 out of 235 publications